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Stable isotope assisted metabolomics techniques have emerged as a valuable tool in systems
biology for metabolic flux analysis and pathway discovery (Duckwall et al., 2013; Chokkathukalam
et al., 2014; Niedenführ et al., 2015). Traditionally, stable isotope labeling analyses have been
highly targeted, meaning that isotopic enrichment of only a small set of metabolites has been
analyzed to deduce metabolic fluxes. However, in recent years, tools for the global non-targeted
detection, quantification, and computational analysis of isotopic enrichment have become available
(Hiller et al., 2010, 2013; Bueschl et al., 2012; Creek et al., 2012; Chokkathukalam et al.,
2013; Cho et al., 2014; Huang et al., 2014). In this article, we will discuss whether and how
such novel non-targeted stable isotope labeling analyses can be applied for systems-biomedical
research.
Pathological alterations of cellular processes usually manifest in altered metabolism. Therefore,
analysis of metabolism is an ideal entry-point to diagnose or analyze diseases. Metabolic fluxes are
the endpoint of cellular regulation and most likely to reflect changes on the genome, transcriptome
or proteome level, and hence, are a valuable read-out for biomedical research (Wegner et al.,
2015). Since intracellular metabolic fluxes cannot bemeasured directly, they are probed using stable
isotope labeling: An isotopically enriched substrate is applied and the metabolization of this tracer
leads to isotopic enrichment in downstream metabolites, depending on the underlying metabolic
fluxes (Buescher et al., 2015). These enrichment patterns are analyzed by mass spectrometry (MS)
or nuclear magnetic resonance (NMR) and are used to deduce metabolic fluxes (Truong et al., 2014;
Young et al., 2014).
Because isotopic labeling patterns are a direct consequence of metabolic fluxes, changes in
these patterns indicate metabolic flux changes (Sauer, 2006). Consequently, global analysis of
labeling patterns would allow for the global detection of metabolic flux changes. Because isotopic
enrichment can be deduced solely from mass spectra (Jennings and Matthews, 2005), differential
flux analysis based on differences in these isotopic labeling patterns does not require prior
compound identification or a model of the metabolic network. This way, a non-targeted stable
isotope labeling analysis can also consider unexpected or unknown compounds and reactions,
circumventing current limitations of compound identification. Such a data-driven metabolic flux
analysis is perfectly suited to pinpoint disease-specific alterations of cellular metabolism as little
information on the experimental outcome is required. However, even in cases where there are
specific hypotheses in place, a data-driven analysis may identify previously overlooked features.
As such, non-targeted stable isotope labeling analysis can function as a hypothesis generator, aiding
the design of subsequent experiments. Other than e.g., 13C metabolic flux analysis (13C-MFA) or
flux balance analysis (FBA) which completely rely on the integrity of the underlying metabolic
network and its constraints, such a non-targeted analysis does not require much biochemical
a priori information and is, therefore, not biased by the limited knowledge of the metabolic
network.
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FIGURE 1 | Different approaches for metabolic analyses. (A) Targeted
and non-targeted analysis of stable isotope labeling (SIL). Non-targeted
detection of isotopic enrichment requires the measurement of an enriched and
a non-enriched sample. Targeted approaches usually have higher sensitivity
toward target analyses, but non-targeted analyses generally yield information
on more compounds. Targeted 13C-MFA provides absolute flux estimates for
a given metabolic network model, but does not provide information on
unknown reactions or metabolites. Non-targeted stable isotope labeling
analysis can point to novel metabolic reactions and metabolites. Differential
mass isotopomer distribution (MID) analysis reveals changes in metabolic
fluxes in a data-driven manner. However, the mechanistic interpretation is
more complex and requires in-depth biochemical knowledge. (B) Comparison
of different metabolic analyses in terms of flux accuracy they provide and to
which extent they allow for the discovery of novel reactions or metabolites.
Non-targeted methods have a higher discovery potential, but fail to provide
accurate absolute flux information.
The experimental effort for a non-targeted stable isotope
labeling study is not much higher than for a conventional
targeted analysis; the main difference is that a non-enriched
sample is required as reference to determine isotopic enrichment
in the sample of interest (Figure 1A; Weindl et al., 2015). In
terms of analytical requirements, the non-targeted analysis
is similar to label-free non-targeted metabolomics: The
wide range of concentrations and chemical heterogeneity of
metabolites pose problems to the metabolome-wide analysis
of isotopic enrichment. Therefore, sensitive and robust
analytics and powerful ion-chromatographic deconvolution
and spectrum matching algorithms are required to accurately
quantify also low-intensity isotopic peaks (Wegner et al.,
2013). Yet, isotopic labeling patterns are much more robust
towards technical variation during sample workup than
metabolite levels, because the labeled and unlabeled species are
subject to the same biases, thus increasing comparability
of different measurements. In comparison to targeted
stable isotope labeling analyses, one faces the problem
of lower sensitivity because single ion (SIM) or selected
reaction monitoring (SRM) cannot be used, as the analytes
of interest are not known beforehand. Apart from that, a
non-targeted approach would yield information on the same
analytes as a targeted analysis, but also include additional
compounds.
If non-targeted stable isotope labeling analysis is that
powerful, why is not more widely applied? There is a great
potential and the experimental effort is manageable, however,
the subsequent data interpretation is much more complex.
Changes in isotopic enrichment can be detected easily and do
not require any biochemical knowledge (Huang et al., 2014).
However, interpreting these changes in terms of underlying
metabolic flux changes requires a deep understanding of cellular
metabolism and is further complicated by the usually high
number of compounds, many of which remain unidentified.
Furthermore, although algorithms for the non-targeted and
quantitative detection of isotopic enrichment in MS data have
been around for a couple of years, non-targeted analysis of stable
isotope labeling is still hampered by the lack of dedicated and
intuitive software tools. For these reasons, only a few studies
have successfully applied non-targeted stable isotope labeling
analysis to provide novel biological insights, underlining the
higher complexity of data interpretation and the need for more
advanced tools and algorithms.
In vivo application of non-targeted stable isotope labeling
analysis is technically possible, but data analysis is complicated
by the metabolic complexity of a whole organism. For that
reason, the main field of application would be in vitro setups
with e.g., cell lines or patient-derived primary cells which
are often applied in biomedical research. In such a context,
non-targeted stable isotope labeling has great potential to
reveal hitherto overlooked metabolic pathways or metabolic flux
changes. Although such non-targeted approaches are not meant
to replace targeted methods and cannot provide absolute flux
information (Figure 1B), they provide means to get closer to the
full picture.
In summary, if the aforementioned limitations can be dealt
with, non-targeted stable isotope labeling analysis is worth
the effort and a valuable addition to the systems biology
toolbox. This rather unbiased approach can help to detect
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flux changes in regions of the metabolic network which were
not expected to be affected or are not known yet, thereby
deepening the understanding of pathobiochemical mechanisms.
This understanding is the basis for the development of novel
diagnostic and therapeutic methods that will impact human
health. Further improvements in sensitivity and specificity of
current algorithms and the development of easy-to-use software
tools will help to realize the great potential of non-targeted stable
isotope labeling analysis.
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